Page last updated: 2024-08-05 12:28:07

macrolide antibiotic

A macrocyclic lactone with a ring of twelve or more members which exhibits antibiotic activity.

ChEBI ID: 25105

Members (34)

MemberDefinitionRole
a 195773A macrolide antibiotic which displays in vitro activity against both gram-positive and gram-negative bacteria and is currently under investigation for the treatment of community-acquired pneumonia. The US Food and Drug Administration (FDA) have also granted orphan drug designation to cethromycin for the treatment of anthrax prophylaxis, tularemia, and plague (PDB entry: 1NWX).cethromycin
amphotericin bA macrolide antibiotic used to treat potentially life-threatening fungal infections.amphotericin B
aplasmomycin(+)-aplasmomycin
bafilomycin a1The most used of the bafilomycins, a family of toxic macrolide antibiotics derived from Streptomyces griseus.bafilomycin A1
boromycinA boron-containing macrolide antibiotic that is isolated from Streptomyces antibioticus.boromycin
brefeldin aA metabolite from Penicillium brefeldianum that exhibits a wide range of antibiotic activity.brefeldin A
candicidinA 38-membered ring lactone containing seven (E)-double bonds between positions 22 and 35 and substituted by hydroxy groups at positions 9, 11, 13, 17 and 19, oxo groups at positions 3, 7 and 15, a carboxy group at position 18, a 3-amino-3,6-dideoxymannopyranosyloxy group at position 21, a methyl group at position 36 and a 7-(4-aminophenyl)-5-hydroxy-4-methyl-7-oxoheptan-2-yl group at position 37. It is the major component of candicidin, a mixture of antifungal heptaene macrolides obtained from a strain of Streptomyces griseus.candicidin D
clarithromycinThe 6-O-methyl ether of erythromycin A, clarithromycin is a macrolide antibiotic used in the treatment of respiratory-tract, skin and soft-tissue infections. It is also used to eradicate Helicobacter pylori in the treatment of peptic ulcer disease. It prevents bacteria from growing by interfering with their protein synthesis.clarithromycin
dirithromycinThe hemi-aminal resulting from the condensation of the erythromycin derivative (9S)-erythromycyclamine with 2-(2-methoxyethoxy)acetaldehyde. As the oxazine ring containing the hemi-aminal group is unstable under both acidic and alkaline conditions, dirithromycin functions as a more lipid-soluble prodrug for (9S)-erythromycyclamine. Administered as enteric coated tablets to protect it from acid catalysed hydrolysis in the stomach, it is used to treat respiratory tract, skin, and soft tissue infections caused by susceptible organisms.dirithromycin
etnangienA macrolide antibiotic isolated from the culture broth of the myxobacterium Sorangium cellulosum and has been found to be active against Gram-positive bacteria.etnangien
gamithromycinA macrolide antibiotic with formula C40H76N2O12. It is used for the treatment of of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle. The compound is also licensed in Europe for the treatment of footrot in sheep caused by Dichelobacter nodosus and Fusobacterium nodosus.gamithromycin
josamycinA macrolide antibiotic produced by certain strains of Streptomyces narbonensis var. josamyceticus.josamycin
methymycinA twelve-membered macrolide antibiotic that is biosynthesised by Streptomyces venezuelae.methymycin
migrastatinA 14-membered macrolide which is isolated from Streptomyces sp.MK929-43F1 and inhibits cell migration of human esophageal cancer EC17 cells and mouse melanona B16 cells.migrastatin
monordenAn antifungal macrolactone antibiotic, obtained from Diheterospora chlamydosporia and Chaetomium chiversii that inhibits protein tyrosine kinase and heat shock protein 90 (Hsp90).radicicol
muconomycin aA trichothecene antibiotic which incorporates a triester macrocyclic structure and an exocyclic methylene epoxide group.verrucarin A
mycaminosyltylonolideA macrolide antibiotic that is tylonolide having a beta-D-mycaminosyl residue attached at position 5.5-O-mycaminosyltylonolide
narbomycinA macrolide antibiotic that is narbonolide having a 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residue attached at position 6. It is biosynthesised by Streptomyces venezuelae.narbomycin
natamycinA macrolide antibiotic that has formula C33H47NO13, produced by several Streptomyces species including Streptomyces natalensis. It exhibits broad spectrum antifungal activity and used in eye drops, and as a food preservative, and also as a postharvest biofungicide for citrus and other fruit crops.natamycin
neomethymycinA twelve-membered macrolide antibiotic that is biosynthesised by Streptomyces venezuelae.neomethymycin
opt 80An 18-membered macrolide that is a fermentation product obtained from the Actinomycete Dactylosporangium aurantiacum. A narrow spectrum antibiotic used for treatment of Clostridium difficile-related infections.fidaxomicin
ossamycinA macrolide antibiotic that was originally isolated from the culture broths of Streptomyces hygroscopicus var. ossamyceticus.ossamycin
pf 1163aA macrolide antibiotic that is 4,10-dimethyl-1-oxa-4-azacyclotridecane-2,5-dione substituted by a 4-(2-hydroxyethoxy)benzyl group at position 3 and a (2R)-2-hydroxypentyl group at position 13 (the 3S,10R,13S stereoisomer). It is isolated from Penicillium sp.PF1163 and exhibits antifungal activity against the pathogenic fungal strain Candida albicans TIMM1768.PF 1163A
pf 1163bA macrolide antibiotic that is 4,10-dimethyl-1-oxa-4-azacyclotridecane-2,5-dione substituted by a 4-(2-hydroxyethoxy)benzyl group at position 3 and a pentyl group at position 13 (the 3S,10R,13S stereoisomer). It is isolated from Penicillium sp.PF1163 and exhibits antifungal activity against the pathogenic fungal strain Candida albicans TIMM1768.PF 1163B
picromycinA macrolide antibiotic that is biosynthesised by Streptomyces venezuelae.pikromycin
rhizoxinAn macrolide antibiotic isolated from the pathogenic plant fungus Rhizopus microsporus. It also exhibits antitumour and antimitotic activity.rhizoxin
rosaramicinA macrolide antibiotic with activity against Neisseria gonorrhoeae, Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis.rosaramicin
streptogramin aA macrolide that is (together with pristinamycin IA) a component of pristinamycin, an oral streptogramin antibiotic produced by Streptomyces pristinaespiralis. Pristinamycin exhibits bactericidal activity against Gram positive organisms including methicillin-resistant Staphylococcus aureus.pristinamycin IIA
tilmicosinA macrolide antibiotic with formula C46H80N2O13. It is used for the treatment of respiratory disease in cattle at high risk of developing bovine respiratory disease associated with Mannheimia haemolytica.tilmicosin
troleandomycinA semi-synthetic macrolide antibiotic obtained by acetylation of the three free hydroxy groups of oleandomycin. Troleandomycin is only found in individuals that have taken the drug.troleandomycin
turimycinA macrolide antibiotic produced by Streptomyces kitasatoensis, showing activity against a wide spectrum of pathogens.leucomycin V
tylosinA macrolide antibiotic that is tylonolide having mono- and diglycosyl moieties attached to two of its hydroxy groups. It is found naturally as a fermentation product of Streptomyces fradiae.tylosin
virginiamycin factor s1A cyclodepsipeptide that is N-(3-hydroxypicolinoyl)-L-threonyl-D-alpha-aminobutyryl-L-prolyl-N-methyl-L-phenylalanyl-4-oxo-L-pipecoloyl-L-2-phenylglycine in which the carboxy group of the 2-phenylglycine moiety has undergone formal intramolecular condensation with the hydroxy group of the N-(3-hydroxypicolinoyl)-L-threonyl to give the corresponding 19-membered ring lactone. It is one of the two major components of the antibacterial drug virginiamycin, produced by Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others.virginiamycin S1
zithromaxA macrolide antibiotic useful for the treatment of bacterial infections.azithromycin

Research

Studies (33,862)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19905,168 (15.26)18.7374
1990's6,617 (19.54)18.2507
2000's9,467 (27.96)29.6817
2010's9,155 (27.04)24.3611
2020's3,455 (10.20)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials3,605 (9.78%)5.53%
Reviews3,419 (9.27%)6.00%
Case Studies6,912 (18.75%)4.05%
Observational190 (0.52%)0.25%
Other22,739 (61.68%)84.16%